 |
Beractant |
|---|---|
| Trade Name | Survanta Intratracheal Suspension |
| Orphan Indication | Persistent pulmonary hypertension of the newborn |
| USA Market Approval | USA |
| USA Designation Date | 1993-12-20 00:00:00 |
| Sponsor | Ross Laboratories;625 Cleveland Avenue;Columbus, Ohio, 43215 |
